The Migraine Trust press releases and statements
Stay up to date with the latest news and stories from The Migraine Trust
14 September NICE approves Rimegepant for acute use on the NHS in England
11 September Rimegepant approved for preventative use in Scotland
31 May NICE approves migraine medication Rimegepant for preventive use on the NHS in England
25 May The Migraine Trust Fellowship recipients announced
9 May SMC approves migraine medication Rimegepant for acute treatment use on the NHS in Scotland
11 April Celebrating March for Migraine 2023
24 March Read the latest edition of our magazine, Migraine News
21 February NICE rejects migraine medication Rimegepant for use on the NHS in England
13 February SMC approves eptinezumab (Vyepti) to treat episodic and chronic migraine
2 February New clinical care pathway for the UK’s 10 million people with migraine
25 January NICE approves eptinezumab (Vyepti) to treat episodic and chronic migraine
14 November Two new fellowships launched
16 September Susan Haydon Bursary recipient publishes migraine and genetics research
8 September Read the latest edition of our magazine, Migraine News
4 September Children and young people with migraine need change now
16 June Donna’s charity golf day for people with migraine
26 May New migraine toolkit launched for UK parliamentarians
11 May Professor Peter Goadsby elected Fellow of the Royal Society
16 September NICE approves fremanezumab (Ajovy) for episodic migraine
5 September New report highlights broken UK migraine healthcare system
22 April Professor Peter Goadsby wins this year’s Scientific Breakthrough Award
12 April Galcanezumab approved for use within NHS Scotland
5 April First Susan Haydon bursaries awarded
11 March Dr Joseph Lloyd awarded PhD for his migraine research
4 March Ground-breaking migraine researchers win this year’s Brain Prize
